Actively Recruiting
Clinical Study of NAFLD and Biomarkers in Obese Chinese Adults Undergoing Bariatric Surgery to Understand Liver Disease Progression
Led by Chinese University of Hong Kong · Updated on 2026-06-23
200
Participants Needed
1
Research Sites
114 weeks
Total Duration
AI-Summary
What This Trial Is About
Nonalcoholic fatty liver disease NAFLD is a common chronic liver condition that can progress to nonalcoholic steatohepatitis NASH, cirrhosis, and liver cancer. This research aims to better understand the clinical course and biomarkers related to NAFLD in obese Chinese adults undergoing bariatric surgery. The study addresses knowledge gaps about how NAFLD develops and progresses, and how to predict and treat it effectively. Participants in this observational study are obese patients, some with NAFLD and some without, who undergo laparoscopic bariatric surgery. During surgery, liver biopsies are taken for detailed tissue analysis to assess the presence and severity of NAFLD and NASH. Clinical and biochemical evaluations are performed before and after surgery to track changes over time. Participants will be closely monitored to determine the prevalence of NAFLD and NASH at the start and after one year. Researchers will examine clinical features and biomarkers that predict disease progression and correlate blood test results with liver tissue findings. The total follow-up period includes assessments at baseline and one year, focusing on disease characteristics and potential indicators for NAFLD and NASH.
CONDITIONS
Brief Title
Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity
Research Team
A
Alice Pik Shan Kong, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here